Bank Of Nova Scotia Ionis Pharmaceuticals Inc Transaction History

Bank Of Nova Scotia

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $1.89 Million - $2.47 Million	51,879 New	51,879 $2.47 Million
Q2 2023 Aug 03, 2023	BUY	$34.73 - $43.33 $1.27 Million - $1.59 Million	36,636 Added 88.48%	78,042 $3.2 Million
Q1 2023 May 11, 2023	BUY	$33.58 - $41.2 $349,433 - $428,727	10,406 Added 33.57%	41,406 $1.48 Million
Q4 2022 Feb 09, 2023	BUY	$37.12 - $46.52 $1.15 Million - $1.44 Million	31,000 New	31,000 $1.17 Million
Q1 2022 May 09, 2022	SELL	$29.88 - $37.04 $18 Million - $22.3 Million	-601,883 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$25.61 - $35.1 $15.1 Million - $20.7 Million	589,568 Added 4787.4%	601,883 $18.3 Million
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $40,918 - $49,471	-1,220 Reduced 9.01%	12,315 $413,000
Q2 2021 Aug 12, 2021	BUY	$34.54 - $47.25 $467,498 - $639,528	13,535 New	13,535 $540,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.